Related Experiment Video
Updated: Aug 10, 2026

08:13
In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
Published on: February 16, 2016
Mobile intensive care in myocardial infarction
British Medical Journal
|July 20, 1968
Summary
A mobile intensive care unit significantly reduced treatment delays for myocardial infarction patients in rural areas. This service improved patient outcomes and justified its cost by enabling faster, more effective care.
Area of Science:
- Emergency Medicine
- Cardiology
- Mobile Healthcare
Background:
- Myocardial infarction (MI) management requires rapid intervention to minimize damage and mortality.
- Rural healthcare access can be limited, increasing delays in critical care delivery.
- Traditional transport methods may delay the initiation of intensive care for acute cardiac events.
Purpose of the Study:
- To evaluate the effectiveness of a mobile intensive care unit (MICU) in a rural setting.
- To assess the impact of the MICU on reducing treatment delays for patients with myocardial infarction.
- To determine the clinical outcomes and cost-effectiveness of implementing a MICU.
Main Methods:
- A mobile intensive care unit was deployed to serve a rural area with a 25-mile radius.
- Data were collected on patient admissions, response times, and clinical interventions over a six-month period.
- Specific focus on patients diagnosed with definite or probable myocardial infarction.
Main Results:
- 95 patients with myocardial infarction were admitted to the hospital via the MICU.
- Average interval from call to initiation of intensive care was under 30 minutes.
- Five cases of ventricular fibrillation were successfully resuscitated outside the hospital.
Conclusions:
- The MICU significantly decreased the delay between symptom onset and intensive care initiation.
- This reduction in delay is crucial for mitigating the risk of primary ventricular fibrillation.
- The MICU's ability to provide immediate care and reduce transport risks justifies its operational costs and resource allocation.
More Related Videos
Related Concept Videos
Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Myocarditis IV: Nursing Management
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

